Dr. Hudis is the Chief Executive Officer of the American Society of Clinical Oncology (ASCO). He also serves as the Executive Vice Chair of its Conquer Cancer Foundation and Chair of ASCO’s CancerLinQ. Dr. Hudis previously served in a variety of volunteer and leadership roles at ASCO, including as its President during the Society’s 50th anniversary year (2013-14). Before coming to ASCO full-time, he was the Chief of the Breast Medicine Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and Professor of Medicine at the Weill Medical College of Cornell University. As CEO of ASCO, Dr. Hudis is responsible for delivering on the board’s strategic goals through education, research, and support for the delivery of the highest quality of care by the Society’s nearly 45,000 members.
Read Dr. Hudis’ Q&A on ASCO Connection.
View current ASCO disclosure here.
Dr. Schilsky is the Chief Medical Officer (CMO) and Executive Vice President of ASCO. Formerly the Chief of Hematology/Oncology in the Department of Medicine and Deputy Director of the University of Chicago Comprehensive Cancer Center, he is a highly respected leader in the field of clinical oncology. He specializes in new drug development and treatment of gastrointestinal cancers. Dr. Schilsky is a Past President of ASCO, having served in the role during 2008-2009, and is also a Past Chair of one of the National Cancer Institute’s Cooperative Groups, Cancer and Leukemia Group B (CALGB).
Dr. Schilsky’s impressive experience and many accomplishments in both clinical medicine and clinical research reflect his deep passion for cancer medicine. He has spent the majority of his career at the University of Chicago, where he joined the faculty in 1984, subsequently rising to the rank of Professor of Medicine and serving in many roles, including Associate Dean for Clinical Research in the Biological Sciences Division and Director of the University of Chicago Cancer Research Center.
From 1995 to 2010, Dr. Schilsky served as Chair of the Cancer and Leukemia Group B (CALGB), a national cooperative clinical research group funded by the National Cancer Institute (NCI). He has extensive experience working with both the NCI and the Food and Drug Administration (FDA) having served as a member and chair of the NCI Board of Scientific Advisors, as a member of the NCI Clinical and Translational Research Committee, and as a member and chair of the Oncologic Drugs Advisory Committee of the FDA. Dr. Schilsky has served on the editorial boards of many cancer journals, including the Journal of Clinical Oncology. He presently serves on the editorial board of the New England Journal of Medicine.
Early in his career, he worked in the Clinical Pharmacology Branch of the Division of Cancer Treatment at the NCI and was an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Missouri-Columbia School of Medicine. He was also the head of the hematology/medical oncology unit at the Harry S. Truman Veterans’ Administration Hospital in Columbia, Missouri.
Ms. Michels serves as ASCO’s Chief Operating Officer and Executive Vice President as well as being the organization’s general counsel and a member of the Executive Leadership Team. She leads ASCO’s Center for Integrity and Law (CEIL), encompassing legal, governance, ethics, and compliance activities. In addition to CEIL, the Human Resources Department falls within her leadership portfolio. Prior to joining ASCO in 2006, Ms. Michels was a partner with Ropes & Gray LLP, in its Corporate Department and Health Care Group. She anchored the firm’s mid-Atlantic health care practice, representing numerous academic medical institutions and hospitals in corporate and regulatory matters. Ms. Michels earned a bachelor’s degree in history and literature from Harvard College, and a law degree with honors from Georgetown University Law Center, where she was an editor of the Georgetown Law Journal. Ms. Michels is a member of the Board of Directors of the Council of Medical Specialty Societies.
Ms. Daly joined ASCO in 2004 as Director of Cancer Research and Policy, where her background in clinical research helped ASCO expand its focus on research issues and efforts. During the following years, ASCO’s Grants Program grew, and she took on the role of Director of Grants for the ASCO Cancer Foundation. In 2009, Ms. Daly assumed the role of Executive Director for the Foundation, which was relaunched as the Conquer Cancer Foundation in 2011. The Conquer Cancer Foundation Grants Program is now one of the largest grants programs among professional societies, with more than $96 million in funding awarded since its inception in 1984. In 2016, she became the Chief Philanthropic Officer and Executive Vice President for the Foundation (ex-officio). In 2020, Ms. Daly assumed the role of Chief Executive Officer for the Foundation.
Prior to joining ASCO, Ms. Daly managed Government Relations for the American Society for Therapeutic Radiology and Oncology (ASTRO). She holds a Bachelor of Science degree from Russell Sage College, and Master of Science and Master of Public Health degrees from Columbia University. She also holds a post-Masters Nurse Practitioner degree from the MGH Institute of Health Professionals.
Mr. Wiegert is the Chief Executive Officer of CancerLinQ, LLC, and Executive Vice President of ASCO. He joined ASCO in 2018, and brings to his role extensive expertise in building and launching innovative technology solutions for healthcare. Mr. Wiegert previously served as Vice President of Product Management for IBM Watson Health, leading the successful launch of major projects, including IBM’s first cloud-based offerings in healthcare.
He also managed the first effort to implement Watson technologies in an FDA-regulated quality management system. Prior to joining IBM, Mr. Wiegert was Vice President of Product Management at Sterling Commerce, where he led the end-to-end product strategy and lifecycle of their selling and fulfillment software suite. He also served at Siebel Systems, where he was responsible for the implementation and design of their sales force automation, call center, integration technology, and analytic solutions. Mr. Wiegert has also held positions with Centura Software Corporation and Safety-Kleen.
Mr. Merlan is the Chief Digital Officer and Executive Vice President of ASCO. He is a digital operations and technology leader with 25 years of successful and diverse experience spanning change management, enterprise architecture, program delivery, strategic planning, and operational leadership. He holds bachelor’s degrees in Psychology and Anthropology from the University of Rhode Island (URI) and continued his studies at URI to pursue his master’s degree in Higher Education Administration.
Prior to joining ASCO, Mr. Merlan led delivery and operations for a digital transformation project at Publicis Groupe. He has also held leadership roles at Sapient and NormaTec. At MIT, he was the Publication Director for the OpenCourseWare initiative, and was the Technology and Practice Manager for Grants Management at Harvard University.
Mr. Merlan is a leader in the technology field, having led high-performing teams at Sapient, MIT, and Harvard. He excels at enabling people and teams to reach their highest potential through open and honest communication and allowing people to take risks and grow.
Ms. Jensen joined ASCO in 2016 with more than 30 years of financial management experience. In her role, she is responsible for financial planning, operations and reporting, as well as treasury and insurance. In addition, she oversees business development and facilities management, including ASCO’s state-of-the-art conference center. She also serves as the Chief Financial Officer for CancerLinQ™ and the Conquer Cancer Foundation. Her focus is on supporting ASCO’s programs and ensuring the organization’s resource allocation aligns with the mission and goals of the organization. She previously served as the Chief Financial Officer of The Jackson Laboratory, an independent biomedical research institution for 10 years. In addition, she worked at Select Energy Services, an energy services provider for 18 years.
Dr. Grubbs joined ASCO in 2015 as the Vice President of the newly launched Clinical Affairs Department. Before joining ASCO, Dr. Grubbs worked as a community oncologist and managing partner at Medical Oncology Hematology Consultants, PA, in Newark, Delaware. Dr. Grubbs is a volunteer and the Principal Investigator of the Delaware Christiana Care National Cancer Institute (NCI) Community Oncology Research Program. He also serves on the advisory council of the Delaware Cancer Consortium, of which he has been a member since 2003.
Ms. Ludwig joined ASCO in late 1997, establishing a department that later became the Communications and Patient Information department. In December 2018, she assumed leadership of a newly merged department, Marketing & Communications. In this capacity, she provides organizational oversight for external communications, media relations/public affairs, social media, patient information, advocate relations, digital and content marketing, member and corporate communications. She and her team also provide support to the Conquer Cancer Foundation and CancerLinQ. Her contributions to public education include the creation and launch of Cancer.Net, an award-winning consumer cancer website, with information on more than 120 cancer types, medical illustrations, podcasts, Spanish translations, and a patient response center.
Ms. Ludwig is an accredited public relations counselor whose background encompasses all aspects of professional communications, with particular expertise in strategic planning, media relations, campaign development, reputation and crisis management. Her experience includes over 25 years of extensive work with non-profit organizations, Fortune 500 companies, and government agencies specializing in scientific, medical, environmental, and public health issues.
Prior to joining ASCO, Ms. Ludwig served as the Director of Marketing and Public Relations for the Society of Nuclear Medicine and as a Senior Account Executive for John Adams Associates, a Washington, DC public affairs firm. In addition, Ms. Ludwig has experience in broadcast advertising and television production, and has worked in the newsrooms of WMJR and WBAL radio stations.
Under her guidance, the department has won a host of awards for: excellence in association publications; videos, PR campaigns and social media; website content, design, and marketing. Ms. Ludwig earned a bachelor’s degree in Communications from Shippensburg University and is an accredited member of the Public Relations Society of America.
Dr. Von Roenn, an ASCO member since 1986, joined the Society professionally in 2013 as the Vice President of Education, Science, and Professional Development (ESPD). In this role, she and her staff collaborate with ASCO members and volunteers to plan, implement, and evaluate all formal US-based education activities (including MOC and CME), provided by ASCO for oncology healthcare professionals. In addition, the ESPD department supports the training and professional development of oncologists throughout the trajectory of their careers. Dr. Von Roenn has served on the ASCO Board of Directors; the ASCO Palliative Care Task Force; the Scientific Program, Cancer Education, and Cancer Communications Committees, among others; the Cancer.Net Editorial Board; and the Leadership Development Working Group. She is also a Fellow of ASCO (FASCO), as well as a previous ASCO-ACS Special Award recipient.
Dr. Von Roenn is board certified in internal medicine, medical oncology, and palliative medicine. Her clinical and research interests focus on breast cancer and palliative care, particularly the impact of treatment on disease-related symptoms. She has previously served as Director of the Palliative Medicine Fellowship Training Program at Northwestern, spearheading efforts throughout Northwestern to incorporate palliative medicine into the medical school curriculum and internal medicine residency training. She also focuses on training medical oncologists to integrate palliative medicine principles and practices into oncology. She served as an editor of the Education in Palliative and End-of-Life Care in Oncology curriculum and as a leadership coach at the San Diego Palliative Care Institute, International Fellows Leadership Development Program. She has actively participated in efforts to develop palliative care services worldwide, serving on several working groups and as faculty for international-focused education courses.
Dr. Von Roenn has served on the editorial board of several oncology and palliative medicine journals, including the Journal of Clinical Oncology, Journal of Cancer Pain & Symptom Palliation and the Journal of Cancer Survivorship. She previously served as Editor in Chief of the Journal of Supportive Oncology. She is a past board member of the American Academy of Hospice and Palliative Medicine and the American Board of Internal Medicine. She has served on numerous committees on breast cancer and palliative care.
Dr. Von Roenn received her bachelor’s degree from the University of Illinois and her medical degree from Rush Medical College. She trained in internal medicine at Presbyterian/St. Luke's Medical Center in Chicago, Illinois.
Ms. King joined ASCO in 2019, and brings to her role about 20 years of experience in corporate human resources. Previously, she served as Vice President of Human Resources for Universities Space Research Association (USRA), where she oversaw the design, development, and implementation of all human resources management functions. Ms. King also led the development of a strategic plan focused on talent management.
In addition, Ms. King was Senior Vice President at NeighborWorks® America, a congressionally chartered nonprofit organization that supports community development in the United States. Prior to joining NeighborWorks® in 2012, she served as Vice President for Operations and Chief Human Resources Officer at the U.S. Institute of Peace, an organization established through an Act of Congress in 1984 that is dedicated to preventing, mitigating, and resolving violent conflicts around the world.
Before her tenure at the Institute of Peace, Ms. King served as Director of Human Resources at the International Life Sciences Institute. During her career, she developed many new initiatives for organizations while fine-tuning existing programs and operations.
Ms. King holds an M.S.A. in Human Resources from Central Michigan University, and a B.S. in Business and Management: Personnel and Labor Relations from the University of Maryland. She also holds certifications as a senior professional in human resources (SPHR), a senior certified professional (SHRM-SCP), a human capital strategist (HCS), and is a certified mediator.
Mr. Lawyer joined ASCO in 2020, and is responsible for leading the enterprise-wide implementation of technology solutions that deliver high-quality, personalized user experiences, streamline processes, and keep data secure. He has more than 25 years of experience in the information technology industry.
Mr. Lawyer served as Assistant Director of IT, Enterprise Systems and Support at Duke University, where he led a multi-disciplinary team and managed large-scale systems and applications. In addition, he served in IT roles at Harvard University and The College of New Jersey. During his career, he has championed the use of enterprise-wide solutions that eliminate redundancies and centralize systems, as well as implementing technology that is as state-of-the-art as it is secure.
Mr. Lawyer holds a B.A. in Mathematics from The College of New Jersey, as well as minors in Statistics and Physics. He also earned certifications in Oracle and Microsoft Systems.
Mr. Pyle joined ASCO in 2007. Mr. Pyle is responsible for directing the international programs of ASCO and advising the Society on the needs and interests of its international members and constituents. He has more than twenty-five years of experience in international affairs in the public, non-profit and corporate sectors. Prior to joining ASCO, Mr. Pyle was the Director of Business Solutions for the International Services department of the American Red Cross, where he led strategic process improvements to the organization's global humanitarian operations.
Earlier in his career, he was the Vice President and Chief Operating Officer for the Center for International Rehabilitation, the Manager for strategic planning/business development for the US subsidiary of Eisai (a Japanese pharmaceutical company), and administered technical assistance projects funded by the U.S. Agency for International Development. Mr. Pyle earned a bachelor's degree in history from Carleton College and a Master of Business Administration degree from Yale University.
Ms. Barnes joined ASCO in 2014 as Vice President of Member Services and is responsible for leading ASCO’s strategic membership growth and development. Through her leadership, the Member Services team provides quality benefits and customer service that deliver high membership value to meet the growing and diverse needs of the ASCO membership.
Ms. Barnes is a membership professional with more than 20 years’ experience in nonprofit organizations. Prior to joining ASCO, she held the position of Assistant Executive Director for Membership, Marketing, and Communication Services at the Council for Exceptional Children. Previously, she has also served in executive membership and marketing positions for the National Recreation and Park Association and the National Council of Teachers of Mathematics. Ms. Barnes is a graduate of Franklin and Marshall College and earned her Master of Business Administration from Marymount University. In addition, Ms. Barnes earned the Certified Association Executive (CAE), the highest certification offered by the American Society of Association Executives.
Dr. Kamin joined ASCO in 1998, leading the Society’s work on a wide range of issues of concern to oncology professionals in all practice settings. Prior to joining ASCO, she directed health policy and benefit design for the Department of Defense civilian health insurance program, TRICARE, which covers more than 9 million beneficiaries worldwide. Dr. Kamin earned a bachelor’s degree in nursing at the Medical College of Georgia, a master’s degree in management science at the Naval Postgraduate School, and a PhD in health policy at the George Washington University.
Ms. Cochran joined ASCO in 2020, and is responsible for the oversight of ASCO’s journals, ensuring practitioners worldwide have the latest evidence-based oncology research to improve patient care and outcomes. She has 22 years of experience managing comprehensive programs in engineering and medical scholarly content.
Ms. Cochran served as Managing Director and Publisher at the American Society of Civil Engineers (ASCE), where she led a self-operated publishing division, oversaw management of multiple digital platforms, and defined strategies for product development and revenue growth. In addition, she served in publishing roles at the American Cancer Society and Pearson Education.
Ms. Cochran’s commitment to the publishing industry and status as a thought leader has been well established. She is first person to be elected president of both the Council of Science Editors and the Society for Scholarly Publishing, and currently serves as Deputy Editor of The Scholarly Kitchen, leading an ongoing dialogue of industry developments.
Ms. Cochran holds a B.A. in English from Stonehill College, as well as a minor in Journalism/Mass Communication.
Ms. Davis-Aitken joined ASCO in 2001. She began her career in ASCO program support and joined the Meetings Services department in 2006. From 2006 to 2017, she oversaw all aspects of ASCO’s Annual Meeting, including exhibits, registration, housing, and logistics. In 2017, she assumed the role of Vice President and is responsible for overseeing ASCO’s meetings program, including the ASCO Annual Meeting and nine symposia and workshops. Her focus is on ensuring that ASCO meetings follow current best practices and consistently incorporate member feedback and innovative technologies that adapt to the evolutionary needs of ASCO members.